COLGATE PALMOLIVE CO — Form 8-K
Filed October 30, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 42/100
What the filing says
Colgate-Palmolive reported Q3 2026 net sales of $5,369M (+4.6% YoY) with organic sales growth of 3.6%. GAAP diluted EPS increased 3% to $0.94; Base Business EPS increased 7% to $0.97. The company narrowed full-year 2026 sales guidance to 4%–5% growth (from 2%–6%), raised gross profit margin guidance to 'up' (from 'roughly flat'), and increased Base Business EPS guidance to 5%–7% growth (from mid-single-digit). Nine-month operating cash flow was $2,913M. No M&A, divestitures, or leadership changes reported.
Why this rating
Solid mid-single-digit organic growth and raised guidance are constructive but incremental. At $73.4B market cap, a $238M Q3 sales beat (~0.3% of annual revenue) and low-single-digit EPS growth do not materially alter trajectory. Routine quarterly earnings.
See more from October 30, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.